Showing results (211-220 of 440) with videos related to
Sort By:
Pageof 44
Journal of the American College of Cardiology|November 16, 2005
Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST StudyPaul A Gurbel, Kevin P Bliden, Waiel Samara, et al.American Heart Journal|September 29, 2014
Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysisDimitrios Alexopoulos, Ioanna Xanthopoulou, Robert F Storey, et al.Journal of Thrombosis and Thrombolysis|December 4, 2017
Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodiumPaul A Gurbel, Kevin P Bliden, Junhong Zhu, et al.Platelets|November 18, 2008
Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic targetPaul A Gurbel, Mark J Antonino, Kevin P Bliden, et al.Journal of Cardiovascular Pharmacology|August 1, 1996
Hemostatic changes after dietary coenzyme Q10 supplementation in swineV L Serebruany, W R Herzog, S P Atamas, et al.Molecular Aspects of Medicine|January 1, 1997
Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?V L Serebruany, P A Gurbel, J V Ordoñez, et al.Journal of Experimental Pharmacology|December 15, 2021
Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One AgentUdaya S Tantry, Karsten Schror, Eliano Pio Navarese, et al.American Heart Journal|July 12, 2011
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studiesKevin P Bliden, Udaya S Tantry, Robert F Storey, et al.European Journal of Heart Failure|August 10, 2000
Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapyV L Serebruany, S R Murugesan, A Pothula, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 18, 2016
The Rationale for and Clinical Pharmacology of Prasugrel 5 mgJoseph A Jakubowski, David Erlinge, Dimitrios Alexopoulos, et al.Pageof 44